The global syndrome therapeutics market size was valued at US$ 147.4 Mn in 2024 and is projected to reach US$ 407.3 Mn by ...

Novo Nordisk (NVO) is deeply undervalued after a 43% YTD decline, despite strong fundamentals and global obesity market ...

FDA label expansion makes selumetinib the second MEK inhibitor approved for adults with neurofibromatosis type 1-associated ...

By implementing an automated 3D cell segmentation process, researchers mapped neurons and muscle fibers at the single-cell ...

LTIMindtree deepens its Microsoft Azure partnership to drive AI-led transformation, boost productivity, and deliver secure ...

Top-tier distribution addition (Muller, Inc.) extends Pennsylvania momentum. On-Premises launch begins early December 2025, Off-Premises rollout ...

Welcome to The Salt Lake Tribune’s 2025 annual report! Back this year, this report is to update you, the community, on what ...

Lifeway Foods achieved significant revenue growth since mid-2024, showcasing resilience despite internal family drama. Read ...

The region is projected to post earnings-per-share growth of 8.4% annually ahead of Southeast Asia, China, emerging Europe ...

A bold US expansion and renewed spending are testing investor faith in Xero's long-term growth story, as its shares slip by ...

The Hershey Company has completed its acquisition of organic snack brand LesserEvil. A move which expands the US ...

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 ...